As of April 16, 2025, Cogent Biosciences (COGT) has a market cap of $0.55 billion USD. According to our data, Cogent Biosciences is ranked No.5835 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.55 B |
-35.65%
|
Dec 31, 2024 | $0.86 B |
32.65%
|
Dec 29, 2023 | $0.65 B |
-49.13%
|
Dec 30, 2022 | $1.28 B |
34.73%
|
Dec 31, 2021 | $0.95 B |
-23.60%
|
Dec 31, 2020 | $1.24 B |
289.93%
|
Dec 31, 2019 | $0.32 B |
-83.64%
|
Dec 31, 2018 | $1.94 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
![]() USA
|
![]() Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
![]() USA
|
![]() Relay Therapeutics
RLAY
|
$0.47 B |
-0.000 M
|
![]() USA
|
![]() Kura Oncology
KURA
|
$0.49 B |
0.000 M
|
![]() USA
|
![]() Zai Lab
ZLAB
|
$3.33 B |
0.000 M
|
![]() China
|
![]() BeiGene
BGNE
|
$20.21 B |
-1.816 B
|
![]() China
|
![]() Exelixis
EXEL
|
$10.23 B |
0.000 M
|
![]() USA
|
![]() Array Technologies
ARRY
|
$0.62 B |
0.000 M
|
![]() USA
|
![]() Agios Pharmaceuticals
AGIO
|
$1.59 B |
0.000 M
|
![]() USA
|
![]() Syndax Pharmaceuticals
SNDX
|
$0.97 B |
0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.06 B |
-0.000 M
|
![]() USA
|
![]() Arcus Biosciences
RCUS
|
$0.85 B |
-0.000 M
|
![]() USA
|
Market Cap | = | COGT Stock Price | * | COGT Shares Outstanding |
= | $4.87 | * | 0.11 B | |
= | $0.55 B |